High HGF Levels are Associated with Response to Bortezomib

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	ŠVÁCHOVÁ Hana POUR Luděk KRÁLOVÁ Dana NĚMEC Pavel ADAM Zdeněk KREJČÍ Marta SANDECKÁ Viera KŘIVANOVÁ Andrea AL SAHMANI Mohamed HÁJEK Roman
Year of publication	2009
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Our previous studies have demonstrated elevated levels of angiogenesis activators such as hepatocyte growth factor (HGF) in the serum of MM patients as negative prognostic value. The aim of this study was to define the role of HGF in peripheral plasma (PP) in MM patients undergoing Bortezomib treatment and its influence on treatment response.
Related projects:	University Research Centre - Czech Myeloma Group From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies